[PDF][PDF] Common sleep disorders affecting older adults

EE Jaqua, M Hanna, W Labib… - The Permanente …, 2022 - thepermanentejournal.org
Sleep disorders in older adults increase with aging, likely due to increased sleep latency,
decreased sleep efficiency, and total sleep time. Common sleep issues include chronic …

Frailty for neurologists: perspectives on how frailty influences care planning

M Canevelli, C Jackson-Tarlton… - The Lancet …, 2024 - thelancet.com
The concept of frailty, now being adopted in most medical disciplines, is attracting growing
interest in neurology. Every day, most neurologists care for patients with varying degrees of …

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

S Banerjee, J High, S Stirling, L Shepstone, AM Swart… - The Lancet, 2021 - thelancet.com
Background Agitation is common in people with dementia and negatively affects the quality
of life of both people with dementia and carers. Non-drug patient-centred care is the first-line …

Polypharmacy among older adults with dementia compared with those without dementia in the United States

ME Growdon, S Gan, K Yaffe… - Journal of the American …, 2021 - Wiley Online Library
Background/objectives In older persons with dementia (PWD), extensive medication use is
often unnecessary, discordant with goals of care, and possibly harmful. The objective of this …

Polypharmacy in older adults with Alzheimer's disease

S Esumi, S Ushio, Y Zamami - Medicina, 2022 - mdpi.com
The number of patients with Alzheimer's disease is increasing annually. Most of these
patients are older adults with comorbid physical illnesses, which means that they are often …

Time to dementia diagnosis by race: a retrospective cohort study

MA Davis, KA Lee, M Harris, J Ha… - Journal of the …, 2022 - Wiley Online Library
Abstract Background Non‐Hispanic Black individuals may be less likely to receive a
diagnosis of dementia compared to non‐Hispanic White individuals. These findings raise …

Dementia prevention and treatment: a narrative review

DB Reuben, S Kremen, DT Maust - JAMA Internal Medicine, 2024 - jamanetwork.com
Importance Dementia affects 10% of those 65 years or older and 35% of those 90 years or
older, often with profound cognitive, behavioral, and functional consequences. As the baby …

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi …

YJJ Wei, N Shrestha, CW Chiang… - Alzheimer's Research & …, 2024 - Springer
Background Limited data exist on the prevalence and trend of central nervous system (CNS)-
active medication polypharmacy among adults with early-onset dementia (EOD) and …

Medicare spending associated with a dementia diagnosis among older adults

GJ Hoffman, DT Maust, M Harris, J Ha… - Journal of the …, 2022 - Wiley Online Library
Abstract Background Over 6 million Americans have Alzheimer's Disease or Related
Dementia (ADRD) but whether spikes in spending surrounding a new diagnosis reflect pre …

Polypharmacy and multiple sclerosis: A population-based study

A Chertcoff, HS Ng, F Zhu, Y Zhao… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: Little is known about polypharmacy and multiple sclerosis (MS). Objectives: To
estimate polypharmacy prevalence in a population-based MS cohort and compare persons …